Tme Pharma N.v. buy melinda
Start price
27.05.23
/
10%
€1.40
Target price
27.05.24
-
Performance (%)
-3.99%
End price
06.06.23
€1.35
Summary
This prediction ended on 06.06.23 with a price of €1.35. With a performance of -3.99%, the BUY prediction by melinda finished with a loss. melinda has 10% into this prediction This prediction was marked as speculative and is excluded from melinda's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Tme Pharma N.v. | -3.185% | -3.185% | 5.263% | -94.294% |
| iShares Core DAX® | 0.271% | 2.504% | 3.327% | 50.436% |
| iShares Nasdaq 100 | 1.884% | 3.490% | 35.658% | 88.226% |
| iShares Nikkei 225® | 3.579% | 8.127% | 56.653% | 65.166% |
| iShares S&P 500 | 0.151% | 1.918% | 24.108% | 64.489% |
According to melinda what are the pros and cons of Tme Pharma N.v. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Tme Pharma N.v. diskutieren
Buy Tme Pharma N.v.